Iovance Biotherapeutics Other Current Liabilities

Iovance Biotherapeutics (IOVA) currently reports a other current liabilities of $78M as of June 2026. That compares with $89M in the prior-year period — down 12.5% year over year. Use the charts on this page to explore Iovance Biotherapeutics's other current liabilities history and peer comparisons.

Iovance Biotherapeutics's other current liabilities decreased from $89M to $78M — a 12.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Iovance Biotherapeutics reported $78M in other current liabilities as of June 2026. That compares with $89M in the prior-year period — down 12.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $78M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Iovance Biotherapeutics, and consider following IOVA for alerts when major investors trade the stock.

Iovance Biotherapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $78M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IOVA with unrelated industries.